Acotec (先瑞达) Pre-IPO: Thoughts on Valuation
We provide our forecast and valuation for the company's two key products AcoArt Orchid & Dhalia, as well as AcoArt Tulip & Litos.
225 Views
Shanghai HeartCare (心玮医疗) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
410 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
446 Views
Acotec (先瑞达) Pre-IPO: Early Mover Advantage in Peripheral DCB
Acotec is early in the peripheral artery drug coated balloon device market with a dominant market share for above-the-knee stenosis. Having said...
383 Views
Pre-IPO Acotec Scientific Holdings - First-Mover Advantage Together with Challenges
This article analyzed Acotec Scientific in terms of its business, industry characteristics, financial position, and also include the concerns and...
402 Views